Should metoprolol be discontinued in a patient with Thevetia (kaner) seed poisoning?

Metoprolol Should Be Discontinued in Thevetia (Kaner) Poisoning

Yes, metoprolol should be discontinued immediately in patients with Thevetia (yellow oleander/kaner) poisoning, as beta-blockers can worsen the already profound bradycardia and cardiac conduction abnormalities caused by cardiac glycoside toxicity.

Understanding the Toxicity

Thevetia peruviana (yellow oleander/kaner) contains cardiac glycosides including thevetins A and B, which act similarly to digoxin by:

• Causing severe bradydysrhythmias and AV nodal blocks
• Producing ventricular tachycardia, ventricular fibrillation, and asystole
• Creating hyperkalemia (though hypokalemia can also occur)
• Inducing gastrointestinal symptoms and confusion 1, 2

Why Metoprolol Must Be Stopped

Beta-blockers like metoprolol directly contradict the pathophysiology of cardiac glycoside poisoning:

• Additive bradycardia: Metoprolol causes bradycardia through beta-1 receptor blockade 3, which compounds the already severe bradycardia from cardiac glycoside-induced AV nodal suppression 1

• Impaired compensatory mechanisms: The FDA label explicitly warns that metoprolol "can cause depression of myocardial contractility and may precipitate heart failure and cardiogenic shock" 3—exactly what kaner poisoning already causes

• Cardiac arrest risk: Metoprolol's FDA label documents "bradycardia, including sinus pause, heart block, and cardiac arrest" 3, which are the primary life-threatening manifestations of yellow oleander poisoning 1, 2

Definitive Treatment Approach

Primary antidote (Class I recommendation):

• Digoxin-specific antibody fragments (digoxin-Fab) are the cornerstone of treatment, with Class 2a evidence specifically for yellow oleander poisoning 1
• Response rates of 50-90% with dysrhythmia resolution in 30-45 minutes 1
• An RCT in hemodynamically stable yellow oleander patients showed promising response 1

For bradydysrhythmias while awaiting or if Fab unavailable:

• Atropine (Class 2b recommendation) for bradycardia 1
• Temporary cardiac pacing (Class 2b) for severe bradydysrhythmias, though complications occur in 36% of cases 1

For ventricular dysrhythmias:

• Lidocaine, phenytoin (Class 2b) until digoxin-Fab can be administered 1

Supportive care:

• Correct hypokalemia (worsens toxicity) and hyperkalemia (use insulin-dextrose, NOT calcium which increases arrhythmia risk) 2
• Activated charcoal if presenting early 2, 4
• Continuous ECG monitoring for at least 24 hours 2

Critical Pitfalls to Avoid

1. Never continue beta-blockers: The combination of cardiac glycoside toxicity plus beta-blockade creates a "double hit" on cardiac conduction that can precipitate complete heart block or asystole

2. Avoid calcium for hyperkalemia: Unlike typical hyperkalemia management, intravenous calcium increases cardiac arrhythmia risk in cardiac glycoside poisoning 2

3. Don't use extracorporeal removal: Hemodialysis, hemofiltration, and plasmapheresis are Class 3 (no benefit) for cardiac glycoside poisoning due to large volume of distribution 1

4. Atropine caution: While it may help bradycardia, some evidence suggests it could theoretically increase tachyarrhythmic deaths by accelerating heart rate 2—use judiciously

Clinical Algorithm

1. Immediate: Discontinue metoprolol
2. Urgent: Administer digoxin-Fab if available (most effective treatment)
3. Temporizing: Use atropine for symptomatic bradycardia if Fab delayed
4. Monitoring: Continuous ECG, serial potassium levels
5. Refractory cases: Consider temporary pacing or VA-ECMO for cardiogenic shock

The evidence is clear: beta-blockers have no role in cardiac glycoside poisoning and should be stopped immediately 1, 2.